|Articles|February 2, 2003
- Pharmaceutical Technology-02-02-2003
- Volume 27
- Issue 2
PhRMA Perspectives on Drug Substance Regulatory Filing Issues
Author(s)Michael Mitchell
The PhRMA API Technical Group examines topics concerning active pharmaceutical ingredient development and manufacture and makes recommendations for regulatory guidance.
Advertisement
Articles in this issue
over 23 years ago
A Stress Testing Benchmarking Studyover 23 years ago
Cleanroom Pressurization Methodologyover 23 years ago
Manufacturing Capability Key to Global Health Advancesover 23 years ago
February 2003over 23 years ago
Outsourcing OutlookAdvertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
What Novartis's $3.2 Billion Enzyme Licensing Deal Means for Formulation
2
AAPS PharmSci 360: CMC Strategies, Part 1
3
CPHI Milan Names 2026 Pharma Awards Finalists
4
AAPS PharmSci 360: Microstructure Intelligence in Predictive Drug Development, Part 1
5